Tero Aittokallio

Quantitative drug sensitivity and resistance testing (DSRT) of primary ex vivo AML blasts highlights mTOR and MEK as potential key molecular driver signals of therapeutic significance (2012)

Cancer Research

Pemovska T, Kylesskiy E, Kontro M, Szwajda A, Karjalainen R, Majumder MM, Malani D, Bespalov MM, Eldfors S, Elonen E, Knowles J, Murumagi A, Mpindi JP, Edgren H, Venkata NPK, Turunen L, Mustjoki S, Wolf M, Yadav B, Aittokallio T, Heckman CA, Porkka K, Kallioniemi O, Wennerberg K

(O2 Muu julkaisu )

A multilevel layout algorithm for visualizing physical and genetic interaction networks, with emphasis on their modular organization (2012)

BioData Mining

Tuikkala J, Vähämaa H, Salmela P, Nevalainen OS, Aittokallio T

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Development of a cancer pharmacopeia-wide ex-vivo drug sensitivity and resistance testing (DSRT) platform for AML: Towards individually optimized therapy and improved understanding of drug resistance patterns (2012)

Cancer Research

Malani D, Pemovska T, Kontro M, Murumagi A, Kulesskiy E, Yadav B, Bespalov M, Eldfors S, Elonen E, Karjalainen R, Knowles JKC, Majumder MM, Mpindi JP, Edgren H, Szwajda A, Venkata NPK, Turunen L, Mustjoki S, Wolf M, Aittokallio T, Heckman CA, Porkka K, Wennerberg K, Kallioniemi O

(O2 Muu julkaisu )

Pravastatin-induced improvement in coronary reactivity and circulating ATP and ADP levels in young adults with type 1 diabetes (2012)

Frontiers in Physiology

Kiviniemi TO, Yegutkin GG, Toikka JO, Paul S, Aittokallio T, Janatuinen T, Knuuti J, Rönnemaa T, Koskenvuo JW, Hartiala JJ, Jalkanen S, Raitakari OT

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Wrapper-based selection of genetic features in genome-wide association studies through fast matrix operations (2012)

Algorithms for Molecular Biology

Pahikkala T, Okser S, Airola A, Salakoski T, Aittokallio T

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Improved Statistical Modeling of Tumor Growth and Treatment Effect in Preclinical Animal Studies with Highly Heterogeneous Responses In Vivo (2012)

Clinical Cancer Research

Laajala TD, Corander J, Saarinen NM, Makela K, Savolainen S, Suominen MI, Alhoniemi E, Makela S, Poutanen M, Aittokallio T

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Optimizing Detection of Transcription Factor-Binding Sites in ChIP-seq Experiments (2012)

Nucleic Acids Research

Elo LL, Kallio A, Laajala TD, Hawkins RD, Korpelainen E, Aittokallio T

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Identification of Personalized Therapeutic Strategies and Associated Biomarkers in Adult Acute Myeloid Leukemia Using a Functional Drug Sensitivity and Resistance Testing Platform (2012)

European Journal of Cancer

Pemovska T, Yadav B, Kulesskiy E, Kontro M, Heckman C, Knowles J, Porkka K, Aittokallio T, Kallioniemi O, Wennerberg K

(O2 Muu julkaisu )

Optimized detection of transcription factor binding sites in ChIP-seq experiments (2012)

Nucleic Acids Research

Elo Laura L, Kallio Aleksi, Laajala T Daniel, Hawkins R David, Korpelainen Eija, Aittokallio Tero

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

High-Throughput Ex Vivo Drug Sensitivity and Resistance Testing (DSRT) Integrated with Deep Genomic and Molecular Profiling Reveal New Therapy Options with Targeted Drugs in Subgroups of Relapsed Chemorefractory AML (2012)

Blood

Heckman CA, Kontro M, Pemovska T, Eldfors S, Edgren H, Kulesskiy E, Majumder MM, Karjalainen R, Yadav B, Szwajda A, Venkata NPK, Murumagi A, Malani D, Parsons A, Hintsanen P, Almusa H, Marti JML, Ellonen P, Mattila P, Lepisto M, Lagstrom S, Suvela M, Mustjoki S, Saarela J, Aittokallio T, Kallioniemi O, Wennerberg K, Porkka K

(O2 Muu julkaisu )

Ota yhteyttä

Linkit

Julkaisut

Järjestä:

Quantitative drug sensitivity and resistance testing (DSRT) of primary ex vivo AML blasts highlights mTOR and MEK as potential key molecular driver signals of therapeutic significance (2012)

A multilevel layout algorithm for visualizing physical and genetic interaction networks, with emphasis on their modular organization (2012)

Development of a cancer pharmacopeia-wide ex-vivo drug sensitivity and resistance testing (DSRT) platform for AML: Towards individually optimized therapy and improved understanding of drug resistance patterns (2012)

Pravastatin-induced improvement in coronary reactivity and circulating ATP and ADP levels in young adults with type 1 diabetes (2012)

Wrapper-based selection of genetic features in genome-wide association studies through fast matrix operations (2012)

Improved Statistical Modeling of Tumor Growth and Treatment Effect in Preclinical Animal Studies with Highly Heterogeneous Responses In Vivo (2012)

Optimizing Detection of Transcription Factor-Binding Sites in ChIP-seq Experiments (2012)

Identification of Personalized Therapeutic Strategies and Associated Biomarkers in Adult Acute Myeloid Leukemia Using a Functional Drug Sensitivity and Resistance Testing Platform (2012)

Optimized detection of transcription factor binding sites in ChIP-seq experiments (2012)

High-Throughput Ex Vivo Drug Sensitivity and Resistance Testing (DSRT) Integrated with Deep Genomic and Molecular Profiling Reveal New Therapy Options with Targeted Drugs in Subgroups of Relapsed Chemorefractory AML (2012)